IMMU-25. RADIO-IMMUNOTHERAPY USING THE IDO PATHWAY INHIBITOR INDOXIMOD FOR CHILDREN WITH NEWLY-DIAGNOSED DIPG
Neuro-oncologyPeer ReviewedTheodore S. Johnson +162018Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support